Chapter 19: Hepatitis & Liver Disease Flashcards
(98 cards)
How is Hepatitis A transmitted
fecal-oral route
through improper hand washing after exposure to an infected person
or via contaminated food/water
How are Hep B and C transmitted
contact with infectious blood or other body fluids
Which type(s) of hepatitis has a vaccine
Hep A and B
First-line treatment for Hep A
Supportive therapy
First-line treatment for Hep B
PEG-INF
NRTI (tenofovir or entecavir)
First-line treatment for Hep C
Treatment naiive: DAA combination (2-3 with different mechs)
Other: DAA combination + RBV or DAA combination + RBV + PEG-INF
DAA treatment lasts 8-12 weeks
What is the purpose of ritonavir for HCV
used to boost levels of HCV protease inhibitors used with it
T/F: DAAs offer a cure for most patients with HCV
DAA = direct acting antiviral
True
Which drug class ends in -privir
NS3/4A Protease inhibitor (P for PI)
Which drug class ends in -asvir
N55A Replication Complex Inhibitor (A for N55A)
Which drug class ends in -buvir
N55B Polymerase Inhibitor (B for N55B)
What do the protease inhibitors used for HIV and HCV have in common?
They are taken with food
Remember: PIG - Protease Inhibitors & Grub
Boxed warning for all DAAs
Risk of reactivating HBV
Warning for sofosbuvir-containing regimens
Serious symptomatic bradycardia
has been reported when amiodarone is taken with sofosbuvir-containing regimen
do not use together
Sofosbuvir/velpatasvir brand name
Epclusa
Glecaprevir/pibrentasvir brand name
Mavyret
How are the tablets in Viekira Pak taken
2 tabs of paritaprevir/ritonavir/ombitasvir once daily in the morning
and 1 dasabuvir tablet twice daily with meals
T/F: Sofosbuvir monotherapy is NOT effective and NOT recommended
True
Which HCV drugs must you avoid or minimize acid suppressive therapy with during treatment
Epclusa
Harvoni
Vosevi
Which HCV drugs are pan-genotypic (approved for all 6 HCV genotypes) for treatment naive
Epclusa
&
Mavyret
CI for paritaprevir/ritonavir/ombitasvir (Technivie)
+ dasabuvir (Viekira Pak)
3A4 substrates or inducers
& use with ethinyl estradiol, lovastatin & simvastatin
Warnings for paritaprevir/ritonavir/ombitasvir (Technivie)
+ dasabuvir (Viekira Pak)
Hepatic decompensation/failure in patients with cirrhosis
risk of increased LFTs
significant drug interaction potential
CI for Elbasvir/grazoprevir (Zepatier)
3A4 inducers
warnings for elbasvir/grazoprevir (Zepatier)
Risk of increased LFTs
significant drug interaction potential